Sonic Healthcare Limited (SAB) Stock Forecast & Price Target

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SAB Analyst Ratings

Hold

2 Buy

6 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Sonic

Healthcare Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SAB Stock 12 Month Forecast

Average Price Target

€13.73

▲(7.60% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Sonic Healthcare Limited in the last 3 months. The average price target is €13.73 with a high forecast of €17.57 and a low forecast of €11.61. The average price target represents a 7.60% change from the last price of €12.76.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","12":"€12","14":"€14","16":"€16","18":"€18"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17.5679175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€17.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.7297094375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€13.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.610102,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€11.61</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,12,14,16,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.13,13.47137826923077,13.812756538461539,14.154134807692309,14.495513076923078,14.836891346153847,15.178269615384616,15.519647884615384,15.861026153846154,16.202404423076924,16.543782692307694,16.88516096153846,17.22653923076923,{"y":17.5679175,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.13,13.176131495192308,13.222262990384616,13.268394485576923,13.31452598076923,13.360657475961538,13.406788971153846,13.452920466346155,13.499051961538463,13.54518345673077,13.591314951923078,13.637446447115385,13.683577942307693,{"y":13.7297094375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.13,13.01308476923077,12.896169538461539,12.779254307692309,12.662339076923077,12.545423846153847,12.428508615384615,12.311593384615385,12.194678153846153,12.077762923076923,11.960847692307691,11.843932461538461,11.727017230769231,{"y":11.610102,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.462,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.594,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.549,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.933,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.688,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":12.357,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":12.81,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.022,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.98,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.9,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.67,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":12.454,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.13,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€17.57

Average Price Target€13.73

Lowest Price Target€11.61

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Macquarie

Not Ranked

Macquarie

€14.42

Buy

13.02%

Upside

Reiterated

07/31/26

Sonic Healthcare Limited (SHL) Gets a Buy from Macquarie

David Stanton

Jefferies

€13.81→€14.05

Hold

10.14%

Upside

Reiterated

07/28/26

Sonic Healthcare Limited (SHL) Receives a Hold from Jefferies

Craig Wong-Pan

RBC Capital

€14.05→€13.44

Hold

5.35%

Upside

Reiterated

07/16/26

RBC Capital Remains a Hold on Sonic Healthcare Limited (SHL)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

€13.02→€13.14

Hold

2.96%

Upside

Reiterated

07/02/26

Sonic Healthcare Limited (SHL) Gets a Hold from Ord Minnett

David Low

UBS

€11.98

Hold

-6.14%

Downside

Reiterated

07/01/26

Sonic Healthcare Limited (SHL) Gets a Hold from UBS

Laura Sutcliffe

Citi

€11.61

Hold

-9.01%

Downside

Reiterated

06/23/26

Citi Keeps Their Hold Rating on Sonic Healthcare Limited (SHL)

Steven Wheen

Jarden

€13.63

Hold

6.79%

Upside

Reiterated

06/15/26

Jarden Sticks to Their Hold Rating for Sonic Healthcare Limited (SHL)

Martyn Jacobs

Bell Potter

€17.57

Buy

37.68%

Upside

Reiterated

06/03/26

Bell Potter Sticks to Its Buy Rating for Sonic Healthcare Limited (SHL)

David Bailey

Morgan Stanley

€15.4→€12.4

Sell

-2.79%

Downside

Downgraded

05/06/26

Sonic Healthcare Limited (SHL) was downgraded to a Sell Rating at Morgan Stanley

Derek Jellinek

Morgans

€17.5

Buy

37.15%

Upside

Reiterated

02/20/26

Morgans Keeps Their Buy Rating on Sonic Healthcare Limited (SHL)

Rita Fung

Wilsons

€17.72

Buy

38.88%

Upside

Reiterated

09/01/25

Wilsons Reaffirms Their Buy Rating on Sonic Healthcare Limited (SHL)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Macquarie

Not Ranked

Macquarie

€14.42

Buy

13.02%

Upside

Reiterated

07/31/26

Sonic Healthcare Limited (SHL) Gets a Buy from Macquarie

David Stanton

Jefferies

€13.81→€14.05

Hold

10.14%

Upside

Reiterated

07/28/26

Sonic Healthcare Limited (SHL) Receives a Hold from Jefferies

Craig Wong-Pan

RBC Capital

€14.05→€13.44

Hold

5.35%

Upside

Reiterated

07/16/26

RBC Capital Remains a Hold on Sonic Healthcare Limited (SHL)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

€13.02→€13.14

Hold

2.96%

Upside

Reiterated

07/02/26

Sonic Healthcare Limited (SHL) Gets a Hold from Ord Minnett

David Low

UBS

€11.98

Hold

-6.14%

Downside

Reiterated

07/01/26

Sonic Healthcare Limited (SHL) Gets a Hold from UBS

Laura Sutcliffe

Citi

€11.61

Hold

-9.01%

Downside

Reiterated

06/23/26

Citi Keeps Their Hold Rating on Sonic Healthcare Limited (SHL)

Steven Wheen

Jarden

€13.63

Hold

6.79%

Upside

Reiterated

06/15/26

Jarden Sticks to Their Hold Rating for Sonic Healthcare Limited (SHL)

Martyn Jacobs

Bell Potter

€17.57

Buy

37.68%

Upside

Reiterated

06/03/26

Bell Potter Sticks to Its Buy Rating for Sonic Healthcare Limited (SHL)

David Bailey

Morgan Stanley

€15.4→€12.4

Sell

-2.79%

Downside

Downgraded

05/06/26

Sonic Healthcare Limited (SHL) was downgraded to a Sell Rating at Morgan Stanley

Derek Jellinek

Morgans

€17.5

Buy

37.15%

Upside

Reiterated

02/20/26

Morgans Keeps Their Buy Rating on Sonic Healthcare Limited (SHL)

Rita Fung

Wilsons

€17.72

Buy

38.88%

Upside

Reiterated

09/01/25

Wilsons Reaffirms Their Buy Rating on Sonic Healthcare Limited (SHL)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

ZURAZura Bio

TNYATenaya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sonic Healthcare Limited

3 Months

Derek JellinekMorgans

Success Rate

6/14 ratings generated profit

Average Return

-0.91%

Copying Derek Jellinek's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -0.91% per trade.

1 Year

Derek JellinekMorgans

Success Rate

7/14 ratings generated profit

Average Return

+9.16%

Copying Derek Jellinek's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +9.16% per trade.

2 Years

Derek JellinekMorgans

Success Rate

7/14 ratings generated profit

Average Return

+10.92%

Copying Derek Jellinek's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +10.92% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SAB Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SAB has received 2 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. SAB average Analyst price target in the past 3 months is 13.73.

Each month's total comprises the sum of three months' worth of ratings.

SAB Financial Forecast

SAB Earnings Forecast

Next quarter’s earnings estimate for SAB is €0.41 with a range of €0.38 to €0.43. The previous quarter’s EPS was €0.31. SAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.15% of the time in the same period. In the last calendar year SAB has Performed in-line its overall industry.

SAB Sales Forecast

Next quarter’s sales forecast for SAB is €3.30B with a range of €3.26B to €3.37B. The previous quarter’s sales results were €3.31B. SAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.91% of the time in the same period. In the last calendar year SAB has Performed in-line its overall industry.

SAB Stock Forecast FAQ

What is DE:SAB’s average 12-month price target, according to analysts?

Based on analyst ratings, Sonic Healthcare Limited’s 12-month average price target is 13.73.

What is DE:SAB’s upside potential, based on the analysts’ average price target?

Sonic Healthcare Limited has 7.60% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Sonic Healthcare Limited a Buy, Sell or Hold?

Sonic Healthcare Limited has a consensus rating of Hold, which is based on 2 buy ratings, 6 hold ratings and 0 sell ratings.

What is Sonic Healthcare Limited’s share price target?

The average share price target for Sonic Healthcare Limited is 13.73. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €17.57 ,and the lowest forecast is €11.61. The average share price target represents 7.60% Increase from the current price of €12.76.

What do analysts say about Sonic Healthcare Limited?

Sonic Healthcare Limited’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of Sonic Healthcare Limited?

To buy shares of DE:SAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Sonic Healthcare Limited (SAB) Stock Forecast & Price Target

SAB Analyst Ratings

SAB Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sonic Healthcare Limited

SAB Analyst Recommendation Trends

SAB Financial Forecast

SAB Earnings Forecast

SAB Sales Forecast

SAB Stock Forecast FAQ

Detailed List of Analyst Forecasts